Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
7.09
-0.24 (-3.27%)
At close: Dec 5, 2025, 4:00 PM EST
7.15
+0.06 (0.85%)
After-hours: Dec 5, 2025, 7:58 PM EST
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$305,667
Profits / Employee
-$148,333
Market Cap
660.89M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MYGN News
- 10 days ago - Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - GlobeNewsWire
- 25 days ago - Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - GlobeNewsWire
- 4 weeks ago - Myriad Genetics: Downgrading To "Hold" Rating On Break-Even Q3 Earnings - Seeking Alpha
- 4 weeks ago - Myriad Genetics, Inc. (MYGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution - GlobeNewsWire
- 5 weeks ago - New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner - GlobeNewsWire
- 5 weeks ago - Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 7 weeks ago - Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel - GlobeNewsWire